Your browser doesn't support javascript.
loading
High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease.
Makishima, Kenichi; Obara, Naoshi; Ishitsuka, Kantaro; Sukegawa, Shinichiro; Suma, Sakurako; Kiyoki, Yusuke; Baba, Naoko; Sakamoto, Tatsuhiro; Kato, Takayasu; Kusakabe, Manabu; Nishikii, Hidekazu; Kurita, Naoki; Yokoyama, Yasuhisa; Sakata-Yanagimoto, Mamiko; Hasegawa, Yuichi; Chiba, Shigeru.
Afiliação
  • Makishima K; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Obara N; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. n-obara@md.tsukuba.ac.jp.
  • Ishitsuka K; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Sukegawa S; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Suma S; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Kiyoki Y; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Baba N; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Sakamoto T; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Kato T; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Kusakabe M; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Nishikii H; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Kurita N; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Yokoyama Y; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Sakata-Yanagimoto M; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Hasegawa Y; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
  • Chiba S; Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Ann Hematol ; 98(4): 1031-1032, 2019 Apr.
Article em En | MEDLINE | ID: mdl-30324459

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transfusão de Eritrócitos / Anticorpos Monoclonais Humanizados / Anemia Hemolítica Autoimune Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transfusão de Eritrócitos / Anticorpos Monoclonais Humanizados / Anemia Hemolítica Autoimune Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article